HCWB (STOCKS)
HCW Biologics Inc. Common Stock
$0.388000
-0.019000 (-4.67%)
Prev close: $0.407000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Hing C. Wong
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.61M
- Employees
- 36
- P/E (TTM)
- -0.03
- P/B (TTM)
- 0.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-3.19 | $-0.86 | -2.3332 | -272.32% |
|
Sep 2025 (Q3)
|
$-2.02 | $-2.35 | +0.3260 | +13.90% |
|
Jun 2025 (Q2)
|
$-1.08 | $1.84 | -2.9160 | -158.82% |
|
Dec 2024 (Q4)
|
$-3.20 | $3.67 | -6.8720 | -187.15% |
Financial Statements
| Revenues | $54.23K |
| Benefits Costs and Expenses | $8.01M |
| Cost Of Revenue | $43.39K |
| Costs And Expenses | $8.01M |
| Gross Profit | $10.85K |
| Nonoperating Income/Loss | $0.00 |
| Operating Expenses | $13.17M |
| Research and Development | $5.44M |
| Other Operating Expenses | $7.73M |
| Operating Income/Loss | -$13.16M |
| Income/Loss From Continuing Operations After Tax | -$7.96M |
| Income/Loss From Continuing Operations Before Tax | -$7.96M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $845.05K |
| Net Income/Loss | -$7.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $14.34M |
| Preferred Stock Dividends And Other Adjustments | $14.34M |
| Basic Earnings Per Share | -$10.63 |
| Diluted Earnings Per Share | -$10.63 |
| Basic Average Shares | 2,097,701 |
| Diluted Average Shares | 2,097,701 |
| Assets | $24.52M |
| Current Assets | $2.28M |
| Accounts Receivable | $32.18K |
| Prepaid Expenses | $222.16K |
| Other Current Assets | $2.03M |
| Noncurrent Assets | $22.24M |
| Fixed Assets | $20.88M |
| Other Non-current Assets | $1.35M |
| Liabilities | $21.76M |
| Current Liabilities | $21.06M |
| Accounts Payable | $13.14M |
| Other Current Liabilities | $7.92M |
| Noncurrent Liabilities | $692.53K |
| Long-term Debt | $0.00 |
| Equity | $2.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.76M |
| Liabilities And Equity | $24.52M |
| Net Cash Flow From Operating Activities | -$13.39M |
| Net Cash Flow From Operating Activities, Continuing | -$13.39M |
| Net Cash Flow From Investing Activities | $2.72M |
| Net Cash Flow From Investing Activities, Continuing | $2.72M |
| Net Cash Flow From Financing Activities | $10.67M |
| Net Cash Flow From Financing Activities, Continuing | $10.67M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$7.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.96M |
| Other Comprehensive Income/Loss | $0.00 |